Abstract: An oscillating conveyor includes a support, a conveying element arranged to carry objects to be moved and supported by the support in order to be displaced between a first extreme position and a second extreme position, and a driving device to displace the conveying element. The driving device includes a crank mechanism, which includes a pendulum pin, which in relation to a rotational axis of the crank mechanism is mounted such that, when the crank rotates, at the pendulum pin an angle between the axis of rotation and a first pivot pin varies within an angular range being either obtuse or acute, resulting in the desired displacement of the conveying element at different speeds, the position of the pendulum pin in relation to the rotational axis being adjustable to vary the displacement speed of the conveyor element.

Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

Abstract: The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.

Abstract: An oscillating conveyor includes a support, a conveying element arranged to carry objects to be moved and supported by the support in order to be displaced between a first extreme position and a second extreme position, and a driving device to displace the conveying element. The driving device includes a crank mechanism, which includes a pendulum pin, which in relation to a rotational axis of the crank mechanism is mounted such that, when the crank rotates, at the pendulum pin an angle between the axis of rotation and a first pivot pin varies within an angular range being either obtuse or acute, resulting in the desired displacement of the conveying element at different speeds, the position of the pendulum pin in relation to the rotational axis being adjustable to vary the displacement speed of the conveyor element.

Abstract: A device adapted to be releasable attached to a blister including at least one piece of medicament. The device includes apparatus for releasable attachment to the blister, a sensor arrangement including at least one first sensor arranged to register the sound of the dispense of a piece of medicament, a time system arranged to register the time and/or date of the dispensing of said piece of medicament and a memory for storing data, such as time and/or date data, related to the dispense of the piece of medicament.

Abstract: The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of A?-related pathologies such as Down's syndrome, ?-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

Abstract: The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.

Abstract: The disclosure relates to a connecting element adapted to temporarily holding together a plurality of articles, the connecting element comprising a base member provided with a first adhesion area adapted to hold a first secondary article to said base member and a second adhesion area adapted to hold a second secondary article to said base member, wherein the adhesion areas comprise an electrically weakable adhesive. Also disclosed is a package and an article being provided with adhesion areas comprising an electrically weakable adhesive.

Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

Abstract: The disclosure relates to a package comprising a first portion and a second portion (or a first package member and a second package member) adapted to be connected to each other and thereby keep the package closed, wherein the first and second portions (or package members) are connected to each other by at least one adhesion area, wherein the adhesion area is adapted to comprise an electrically weakable adhesive. The disclosure further relates to a method of closing and opening a package.

Abstract: The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.

Abstract: The present invention concerns a device (14) adapted to be releasable attached to a blister (10) including at least one piece of medicament (13). The device (14) comprises means for releasable attachment to said blister (10) a sensor arrangement including at least one first sensor arranged to register the sound of the dispense of a piece of medicament (13), a time system arranged to register the time and/or date of the dispensing of said piece of medicament (13) and a memory for storing data, such as time and/or date data, related to the dispense of said piece of medicament.

Abstract: A package includes a top panel, a bottom panel, a first side panel connecting the top panel and the bottom panel to each other and a second side panel also connecting the top panel and the bottom panel to each other. The bottom panel, the first side panel, the top panel and the second side panel form a sleeve having a cross-section essentially formed as a rectangle. The sleeve is adapted to slidably receive an insert along a sliding direction normal to the rectangle. The package includes a locking member which includes an arch-shaped portion extending into the rectangular cross section to releasably retain the insert. The present disclosure also relates to a blank for forming the package.

Abstract: A support system (1) for the suspension of a roller broom (2) on a sweeping vehicle comprises a rotary support (3) mounted to turn on the sweeping vehicle around a vertical slewing axis (7), a support part (5) suspended on the rotary support via a lifting mechanism (4) comprising a lifting drive (26), and a broom frame (6) mounted on the support part to rock around a horizontal axis (16) extending perpendicular to the axis of rotation (L) of the roller broom. For this purpose there is provided, in the region of the pendulum bearing (14) of the broom frame, a movably mounted locking member (17), which can occupy a first position that enables the rocking movement of the broom frame and a second position that disables the rocking movement of the broom frame in its leveled condition, and on which the lifting drive of the lifting mechanism acts in such a way that the locking member occupies its second position when the lifting drive is activated.

Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

Abstract: The invention relates to a laminate structure comprising a first carrier layer with a surface, a first active surface being electrically conducting and being supported by the first carrier layer, a second active surface being electrically conducting and being supported by the first carrier layer, wherein the first active surface is separated from the second active surface a first distance along the surface of the first carrier layer, wherein the laminate structure is adapted to receive an electrically weakable adhesive bridging said distance between the active surfaces. The invention further relates to a method of producing such a laminate structure.

Abstract: The invention relates to a laminate structure comprising a first active layer having a first electrode potential, a second active layer having a second electrode potential, wherein the second electrode potential being different from the first electrode potential and wherein the first and second active layers are arranged at a distance from each other, and wherein the laminate further comprises a third layer of an electrically weakable adhesive at least partly bridging said distance between the first and second layers.

Abstract: The disclosure relates to a connecting element adapted to temporarily holding together a plurality of articles, the connecting element comprising a base member provided with a first adhesion area adapted to hold a first secondary article to said base member and a second adhesion area adapted to hold a second secondary article to said base member, wherein the adhesion areas comprise an electrically weakable adhesive. Also disclosed is a package and an article being provided with adhesion areas comprising an electrically weakable adhesive.

Abstract: The disclosure relates to a package comprising a first portion and a second portion (or a first package member and a second package member) adapted to be connected to each other and thereby keep the package closed, wherein the first and second portions (or package members) are connected to each other by at least one adhesion area, wherein the adhesion area is adapted to comprise an electrically weakable adhesive. The disclosure further relates to a method of closing and opening a package.